Liabilities, Current in USD of Caribou Biosciences, Inc. from Q4 2020 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Caribou Biosciences, Inc. quarterly Liabilities, Current history and growth rate from Q4 2020 to Q3 2025.
Caribou Biosciences, Inc. Liabilities, Current for the quarter ending September 30, 2025 was $28.1M, a 12.8% decline year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Caribou Biosciences, Inc. Quarterly Liabilities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$28.1M	-$4.1M	-12.8%	Sep 30, 2025	10-Q	2025-11-12
Q2 2025	$28.9M	-$2.06M	-6.65%	Jun 30, 2025	10-Q	2025-08-12
Q1 2025	$28.5M	-$530K	-1.83%	Mar 31, 2025	10-Q	2025-05-08
Q4 2024	$30.7M	+$2.35M	+8.3%	Dec 31, 2024	10-Q	2025-11-12
Q3 2024	$32.2M	+$7.59M	+30.9%	Sep 30, 2024	10-Q	2024-11-06
Q2 2024	$30.9M	-$3.43M	-9.98%	Jun 30, 2024	10-Q	2024-08-06
Q1 2024	$29M	+$1.92M	+7.09%	Mar 31, 2024	10-Q	2024-05-07
Q4 2023	$28.3M	+$174K	+0.62%	Dec 31, 2023	10-K	2025-03-10
Q3 2023	$24.6M	-$4.24M	-14.7%	Sep 30, 2023	10-Q	2023-11-07
Q2 2023	$34.4M	+$5.52M	+19.1%	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	$27.1M	+$433K	+1.62%	Mar 31, 2023	10-Q	2023-05-09
Q4 2022	$28.1M	+$2.3M	+8.9%	Dec 31, 2022	10-K	2024-03-11
Q3 2022	$28.8M	+$2.66M	+10.2%	Sep 30, 2022	10-Q	2022-11-08
Q2 2022	$28.9M	+$2.85M	+11%	Jun 30, 2022	10-Q	2022-08-09
Q1 2022	$26.7M			Mar 31, 2022	10-Q	2022-05-09
Q4 2021	$25.8M	+$13.4M	+108%	Dec 31, 2021	10-K	2023-03-09
Q3 2021	$26.2M			Sep 30, 2021	10-Q	2021-11-09
Q2 2021	$26M			Jun 30, 2021	10-Q	2021-09-02
Q4 2020	$12.4M			Dec 31, 2020	10-K	2022-03-21

* An asterisk sign (*) next to the value indicates that the value is likely invalid.